Kanako Saito

4PUBLICATIONS
7CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 23, 2026
Immune checkpoint inhibitor-associated uveitis in a patient with breast cancer and a remote history of Vogt-Koyanagi-Harada disease: a case report.

|Apr 20, 2026
Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.

|Apr 13, 2026
Endocrinologist-Led Management of Endocrine Immune-Related Adverse Events: Real-World Evidence Supporting the Japan Endocrine Society Guidelines.

Kota Nishihama, Hajime Fujimoto, Kanako Saito

|Dec 20, 2024
Evaluation of MAGE-A4 expression in breast cancer and its impact on prognosis.

Kaho Nakamura, Kanako Saito, Chihiro Higashi

Pageof 1

Frequent Collaborators

1 joint publications

Mikiya Ishihara

1 joint publications

Kota Nishihama

1 joint publications

Akira Tsunoda

1 joint publications

Toshiro Mizuno